Application of Ultrasonographic Imaging in Fetal Thyroid Function Measurement of Amniotic Hormone Concentration

Abstract

Objective: To investigate the fetal thyroid function using ultrasound imaging combined with amniotic fluid hormone concentration. Method: 380 pregnant women who did pregnancy test in our hospital from August 2015 to August 2017 were selected as the subjects. 260 of them had normal fetal growth indicators, all of them were singletons, with a gestational time of 18–41 weeks. 120 pregnant women underwent cesarean section, parturition, and amniocentesis. All pregnant women had no thyroid related diseases, hypertension, or autoimmune diseases. 3DUS (Three-dimensional ultrasound) and 2DUS (two-dimensional ultrasound) were used to measure the size of fetal thyroid gland, and the amniotic hormone content was measured. Result: The repeatability and consistency of the 3DUS-VOCAL (Voual organ computerized analysis) technique were superior to 2DUS in the measurement of fetal thyroid volume in 20 cases. There were 243 fetal thyroid size-related data collected from 260 fetuses at 18 weeks and 41 weeks of pregnancy. Amniotic fluid FT3, T3 had a certain correlation with gestational age, but amniotic fluid FT4, T4, TSH had no significant correlation with gestational age. 4 cases of fetal hypothyroidism were screened by ultrasound combined with amniotic fluid hormone measurement. Conclusion: The volume of fetal thyroid measured by 3DUS-VOCAL is better than that of 2DUS. Ultrasound combined with amniotic fluid thyroid associated hormone detection is helpful to evaluate fetal thyroid function.